The Two-Way Relationship Between Diabetes and Periodontal Disease
The Two-Way Relationship Between Diabetes and Periodontal Disease
The Two-Way Relationship Between Diabetes and Periodontal Disease
This is the third in a series of research articles delivered at the RCDSO Symposium, ORAL HEALTH: A WINDOW TO SYSTEMIC DISEASE, on February 4, 2005.
This PEAK article is a special membership service from RCDSO. The goal of PEAK (Practice Enhancement and Knowledge) is to provide Ontario dentists with key articles on a wide range of clinical and non-clinical topics from dental literature around the world. PLEASE KEEP FOR FUTURE REFERENCE.
RCDSO would like to express its thanks to the Canadian Dental Association as this article updates and expands on an earlier article by Dr. Debora C. Matthews, which appeared in the Journal of the Canadian Dental Association, 2002;68(3):161-164.
Diabetes mellitus (DM) is a highly prevalent metabolic disease, affecting one in ten Canadians. In many of these people, the disease remains undiagnosed.1,2 More importantly, the prevalence of DM has tripled since 1970. This is a significant finding for dental professionals, as evidence from clinical research showing a strong relationship between diabetes and periodontal disease is mounting. In fact, periodontitis is often referred to as the sixth complication of diabetes.3 Further research suggests that control of periodontal disease may play a key role in the control of diabetes. Thus, dentists must be aware of the signs and symptoms of diabetes, and understand the importance of maintaining periodontal health for anyone with diabetes.
With type 2 diabetes, patients can still produce insulin, but do so relatively inadequately. In many cases, the pancreas produces larger than normal quantities of insulin. A major feature of type 2 diabetes is a lack of sensitivity to insulin by the cells of the body, particularly fat and muscle cells. These larger quantities of insulin are produced as an attempt to get these cells to recognize that insulin is present. In addition to the problems with an increase in insulin resistance, the release of insulin by the pancreas may also be defective, and occur late in response to increased glucose levels. Finally, the liver in these patients continues to produce glucose despite elevated glucose levels. There is a direct relationship between the degree of obesity and the risk of developing type 2 diabetes in both children and adults. It is estimated that the chance to develop diabetes doubles for every 20% increase over desirable body weight and for each decade after 40 years of age, regardless of weight. The prevalence of diabetes in persons 65 to 74 years of age is nearly 20%.4,5 Compared with a 6% prevalence in Caucasians, the prevalence in African Americans and Asian Americans is estimated to be 10%, in Hispanics 15%, and in certain Native American tribes 20% to 50%.1,6 People with type 2 diabetes constitute 90% of the diabetic population. Gestational diabetes mellitus (GDM) is glucose intolerance that begins during pregnancy. The children of mothers with GDM are at greater risk of experiencing obesity and diabetes as young adults.7 As well, there is a greater risk to the mother of developing type 2 diabetes in the future. A wide variety of relatively uncommon conditions fall into the category of other specific types. These consist mainly of specific genetically defined forms of diabetes and diabetes associated with other diseases, such as pancreatitis or drug use.
Complications of Diabetes
Long-term complications may occur in both type 1 and type 2 diabetes.3,7 Diabetes accelerates atherosclerosis of the larger blood vessels, leading to coronary heart disease (angina or heart attack), strokes, and pain in the lower extremities because of lack of blood supply. Microvascular complications include retinopathy (which may lead to blindness), nephropathy (possibly leading to kidney failure) and neuropathy.
Signs and Symptoms of Acute Hypoglycemia dizziness pallor anxiety, including agitation and belligerence Sweating tachycardia weakness hunger It is strongly advisable to have some form of rapidly absorbed glucose, such as orange juice, on hand when treating patients with diabetes. To avoid an episode of hyperglycemia consider the following Schedule the patient at their time of highest insulin activity. This depends upon the type of insulin used and may vary from 30 minutes to eight hours post-injection. Advise the patient not to change their insulin regimen or diet prior to their treatment. Have a blood glucose monitor in the office or ask patient to bring theirs to the appointment. Consider pre-operative sedation for anxious patients. From this review of the clinical evidence to date, we can conclude that prevention and control of periodontal disease must be considered an integral part of diabetes control. The principles of treatment of periodontitis in diabetic patients are the same as those for non-diabetic patients and are consistent with our approach to all high-risk patients who already have periodontal disease (see Table 2). Major efforts should be directed at preventing periodontitis in patients who are at risk of diabetes. Diabetic patients with poor metabolic control should be seen more frequently, especially if periodontal disease is already present. Patients with wellcontrolled diabetes, who have good oral hygiene and who are on a regular periodontal maintenance schedule, have the same risk of severe periodontitis as nondiabetic patients.
Periodontal maintenance
Annually
At each visit Every 6 months Every 6 months Annually Every 4-6 months
Annually
Annually
At each visit
References 1. Tan M, Daneman D, Lau D, others a. Diabetes in Canada: strategies towards 2000. Toronto; 1997. 2. Tan MH, MacLean DR. Epidemiology of diabetes mellitus in Canada. Clinical Investigative Medicine 1995;18(4):240-6. 3. Loe H. The sixth complication of diabetes mellitus. Diabetes Care 1993;16(1):329-334. 4. Shay K. Infectious complications of dental and periodontal diseases in the elderly population. Clinical Infectious Diseases 2002;34(9):1215-1223. 5. Ghezzi EM, Ship JA. Systemic diseases and their treatments in the elderly: impact on oral health. Journal of Public Health in Dentistry 2000;60(4):289-296. 6. Skrepcinski FB, Niendorff WJ. Periodontal disease in American Indians and Alaska Natives. Journal of Public Health in Dentistry 2000;60(Suppl 1):261-266. 7. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, et al. 1998 clinical practice guidelines for the management of diabetes . Canadian Medical Association Journal 1998;159(Suppl 8):S1-29. 8. Rees T. Periodontal management of the patient with diabetes mellitus. Diabetes Care 2000;23(1):63-72. 9. Lalla RV, DAmbrosio J. Dental management and considerations for the patient with diabetes mellitus. Journal of the American Dental Association 2001;132(10):1425-32. 10. Firatli E. The relationship between clinical periodontal status and insulin-dependent diabetes mellitus. Results after 5 years. Journal of Periodontology 1997;68(2):136-40. 11. Grossi SG, Zambon JJ, Ho AW, Koch G, Dunford RG, Machtei EE, et al. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. Journal of Periodontology 1994;65(3):260-7. 12. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: an epidemiologic perspective. Annals of Periodontology 2001;6(1):99-112. 13. Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, et al. The severity of periodontal disease is associated with the development of glucose intolerance in non-diabetics: the Hisayama study. Journal of Dental Research 2004;83(6):485-90. 14. Lagervall M, Jansson L, Bergstrom J. Systemic disorders in patients with periodontal disease. Journal of Clinical Periodontology 2003;30(4):293-9. 15. Tervonen T, Karjalainen K. Periodontal disease related to diabetic status. A pilot study of the response to periodontal therapy in type 1 diabetes. Journal of Clinical Periodontology 1997;24(7):505-510. 16. Grossi SG, Skrepcinski FB, DeCaro T, Robertson RG, others a. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. Journal of Periodontology 1997;68(8):713-19. 17. Martorelli de Lima AF Cury CC, Palioto DB, Duro AM, da Silva RC, Wolff LF Therapy with adjunctive , . doxycycline local delivery in patients with type 1 diabetes mellitus and periodontitis. Journal of Clinical Periodontology 2004;31(8):648-53. 18. Christgau M, Palitzsch KD, Schmalz G, Kreiner U, Frenzel S. Healing response to non-surgical periodontal therapy in patients with diabetes mellitus: clinical, microbiological, and immunologic results. Journal of Clinical Periodontology 1998;25(2):112-124. 19. Matthews DC. The relationship between diabetes and periodontal disease. Journal of the Canadian Dental Association 2002;68(3):161-164. 20. Stewart JE, Wager KA, Friedlander AH, Zadeh HH. The effect of periodontal treatment on glycemic control in patients with type 2 diabetes mellitus. Journal of Clinical Periodontology 2001;28(4):306-10. 21. Westfelt E, Rylander H, Blohme G, Jonasson P, Lindhe J. The effect of periodontal therapy in diabetics. Results after 5 years. Journal of Clinical Periodontology 1996;23(2):92-100.
Notes
10
Notes
11
6 Crescent Road Toronto ON Canada M4W 1T1 T: 416.961.6555 F: 416.961.5814 Toll Free: 800.565.4591 www.rcdso.org
12